Does firm’s network position enhance open innovation performance? Evidences from the biopharmaceutical industry

Abstract

This paper explores the relationship between open innovation (OI) and firm's network position on enhancing firm's innovation performance, such as new product development (NPD). We build a theoretical framework and test it on the biopharmaceutical context. Our result shows how firm's network position influences NPD performance obtained through OI practices.